Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702516 | Urologic Oncology: Seminars and Original Investigations | 2017 | 9 Pages |
Abstract
The currently available evidence suggests that ADT in the treatment of prostate cancer is associated with an increased risk of depression.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kevin T. M.D., M.Phil., Sumi M.D., David D. B.A., Paul L. M.D.,